Tel: 01789 267520

Roche’s Sunfish Clinical Trial – why didn’t it happen here/what about access to future trials?

28 June 2018 / Posted in: Research

We asked GOSH if they could throw any light on this and what assurances they could give that the UK won’t miss out in the future. Also, we checked what actions anyone interested in being considered for a clinical trial should take.

Read full story

Consultation About Screening For SMA

27 June 2018 / Posted in: Research

The National Screening Committee (NSC) has invited us to give comments and feedback on its June 2018 evidence review. We will be collating views on this.

Read full story

NICE Committee Meeting

27 June 2018 / Posted in: Research

Today, we are at the NICE Committee Meeting in Manchester which is considering whether to recommend access to nusinersen; we will know the outcome in 3 – 4 weeks’ time. Thanks to the other two Patient Representatives who are also attending.

Read full story

Speaking Up For Provision Of Cough Assist Machines

26 June 2018 / Posted in: Information & Support

A group of three West Midlands CCGs are reviewing their policy on cough assists, which could result in patients being denied this vital piece of equipment. We have added our voice to protest against this.

Read full story

Young People Wanted to get Involved in DR UK Research

25 June 2018 / Posted in: Information & Support

Disability Rights UK is looking for disabled young people aged 12-18 years to become members of the project advisory board for a research project looking at attitudes towards disability and disabled people amongst their peers.

Read full story

Thank you for supporting Marathon in May for SMA Thank you for supporting Marathon in May for SMA

21 June 2018 / Posted in: Help Us

We would like to say a huge Thank You to everyone who has supported the very first Marathon in May for SMA.

Read full story

PTC Therapeutics Present Interim Data from FIREFISH Clinical Trial

21 June 2018 / Posted in: Research

PTC Therapeutics recently presented preliminary data from the FIREFISH Phase II clinical trial of their splice-modifying drug, RG7916, at the 2018 Cure SMA conference in Dallas, USA.

Read full story

Cytokinetics Release CK-2127107 Phase II Clinical Trial Data

20 June 2018 / Posted in: Research

Cytokinetics presented data at the 2018 Cure SMA conference from the Phase II clinical trial with SMA patients of its drug CK-2127107, which has been renamed reldesemtiv.

Read full story

Cabinet Secretary for Health and Sport in Scotland Outlines New Pathway For Medicines

19 June 2018 / Posted in: Research

A statement came out yesterday that explains how patients with rare diseases in Scotland could get faster access to new treatments following a revised decision-making process. The Scottish Government is introducing a new definition of 'ultra-orphan medicines' that can treat rare conditions.

Read full story

Summer Fundraising Events in Scotland Summer Fundraising Events in Scotland

19 June 2018 / Posted in: Help Us

Find out more about exciting events that are happening in Scotland over the summer which you could take part in to help raise money for SMA Support UK.

Read full story